Derbend Asset Management Pfizer Inc Transaction History

Derbend Asset Management

$200 Million
Q1 2024

A detailed history of Derbend Asset Management transactions in Pfizer Inc stock. As of the latest transaction made, Derbend Asset Management holds 10,232 shares of PFE stock, worth $292,737. This represents 0.14% of its overall portfolio holdings.

Number of Shares

10,232

Previous 10,679 4.19%

Holding current value

$292,737

Previous $307,000 7.82%

% of portfolio

0.14%

Previous 0.18%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $11,572 - $13,289	-447 Reduced 4.19%	10,232 $283,000
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $4,311 - $5,600	-165 Reduced 1.52%	10,679 $307,000
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $17,553 - $20,517	-547 Reduced 4.8%	10,844 $359,000
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $48,762 - $56,416	-1,350 Reduced 10.6%	11,391 $417,000
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $34,387 - $44,767	-873 Reduced 6.41%	12,741 $519,000
Q4 2022 Jan 24, 2023	SELL	$41.75 - $54.5 $44,004 - $57,443	-1,054 Reduced 7.19%	13,614 $0
Q3 2022 Oct 20, 2022	BUY	$43.76 - $53.42 $1,400 - $1,709	32 Added 0.22%	14,668 $642,000
Q2 2022 Jul 21, 2022	SELL	$46.53 - $55.17 $86,080 - $102,064	-1,850 Reduced 11.22%	14,636 $767,000
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $7,933 - $11,760	-192 Reduced 1.15%	16,486 $974,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $28,888 - $37,109	-736 Reduced 4.23%	16,678 $717,000
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $625,336 - $708,401	17,414 New	17,414 $682,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Derbend Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Derbend Asset Management with notifications on news.

Account

Derbend Asset Management Pfizer Inc Transaction History